Australia Basal Cell Carcinoma Treatment Market Size & Outlook
Australia basal cell carcinoma treatment market, 2018-2030 (US$M)
Related Markets
Australia basal cell carcinoma treatment market highlights
- The Australia basal cell carcinoma treatment market generated a revenue of USD 132.5 million in 2023 and is expected to reach USD 279.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 11.3% from 2024 to 2030.
- In terms of segment, surgery was the largest revenue generating type in 2023.
- Intralesional injections is the most lucrative type segment registering the fastest growth during the forecast period.
Basal cell carcinoma treatment market data book summary
| Market revenue in 2023 | USD 132.5 million |
| Market revenue in 2030 | USD 279.8 million |
| Growth rate | 11.3% (CAGR from 2023 to 2030) |
| Largest segment | Surgery |
| Fastest growing segment | Intralesional injections |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications |
| Key market players worldwide | Bausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare |
Other key industry trends
- In terms of revenue, Australia accounted for 4.5% of the global basal cell carcinoma treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Australia basal cell carcinoma treatment market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 260.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Basal Cell Carcinoma Treatment Market Scope
Basal Cell Carcinoma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia basal cell carcinoma treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 35.92% in 2023. Horizon Databook has segmented the Australia basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.
Australia has one of the highest rates of skin cancer globally, with about two-thirds of Australians expected to be diagnosed with some form of skin cancer before turning 70. BCC can occur in young individuals and is more common in those over 40, while SCC primarily affects individuals over 50 in Australia.
According to the International Agency for Research on Cancer, in 2022, NMSC prevalence reported in Australia was 59,265. To address this significant health issue, Wellbeing SA and Cancer Council SA have collaborated to launch the first South Australian Skin Cancer Prevention.
Reasons to subscribe to Australia basal cell carcinoma treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia basal cell carcinoma treatment market databook
-
Our clientele includes a mix of basal cell carcinoma treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia basal cell carcinoma treatment market , including forecasts for subscribers. This country databook contains high-level insights into Australia basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia basal cell carcinoma treatment market size, by type, 2018-2030 (US$M)
Australia Basal Cell Carcinoma Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
